Boston An independent LDT provider
NOTE:Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here: https://rb.gy/09bxx

Share capital development

The table below shows the historical development for the Company’s share capital for the period covered by the selected historical financial information:

Date of registrationActivityChangeTotalChangeTotal
10/06/20Subscription of shares through warrants28 50022 631 5811 425.001 131 579.05
06/04/20New issue of shares2 948 22822 603 081147 411.401 130 154.05
09/09/19Subscription of shares through warrants123 50019 654 8536 175.00982 742.65
09/19/18Subscription of shares through warrants50 50019 531 3532 525.00976 567.65
06/08/18New issue of shares2 162 79419 480 853108 139.70974 042.65
10/04/17Subscription of shares through warrants10 00017 318 059500.00865 902.95
10/04/17Subscription of shares through warrants504 00017 308 05925 200.00865 402.95
10/28/16New issue of shares44 40916 804 0592 220.45840 202.95
10/26/16New issue of shares285 08216 759 65014 254.10837 982.50
09/27/16New issue of shares119 30016 474 5685 965.00823 728.40
09/22/16New issue of shares2 064 05216 355 268103 202.60817 763.40
12/17/15New issue of shares13 60014 291 216680.00714 560.80
11/30/15New issue of shares781 40014 277 61639 070.00713 880.80
11/18/15New issue of shares2 450 00013 496 216122 500.00674 810.80
08/13/15Bonus issue011 046 216331 386.48552 310.80
Home Stock information The Share Share capital development